Business Description
Founded in 1975 and headquartered in Ashiya, Japan, JCR Pharmaceuticals researches, manufactures, and sells medicines that treat rare and serious conditions such as growth hormone deficiency, Fabry disease, and graft-versus-host disease. The company also works on treatments for kidney-related anemia and is exploring gene therapy approaches targeting diseases of the central nervous system. Beyond its own product line, JCR trades in medical devices and research equipment, and partners with international firms to develop next-generation biological treatments.